BTK INHIBITOR COMPOUNDS

The invention provides BTK Inhibitor compounds of the formulapharmaceutically acceptable salts, pharmaceutical compositions thereof, and methods of using these compounds, salts, or compositions to treat autoimmune diseases such as Rheumatoid Arthritis.

Saved in:
Bibliographic Details
Main Authors HENRY Kenneth James JR, KUKLISH Steven Lee, PARTRIDGE Katherine Marie, KHILEVICH Albert, QUIMBY Steven James
Format Patent
LanguageEnglish
Slovenian
Published 28.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides BTK Inhibitor compounds of the formulapharmaceutically acceptable salts, pharmaceutical compositions thereof, and methods of using these compounds, salts, or compositions to treat autoimmune diseases such as Rheumatoid Arthritis.
Bibliography:Application Number: SI20180030523T